An investigation. Parents have always been a little concerned about their kids watching cartoons. They worry that their children watch cartoons too often, or the shows are violent. But what if a cartoon had the power to actually hurt your kid? That was the situation in December 1997, when an episode of Pokémon aired in Japan and tens of thousands of children reportedly experienced seizures—a phenomenon dubbed the “Pokémon shock.” The episode caused widespread panic and the show went on a four-month hiatus, nearly getting cancelled. But years later, a researcher discovered that the story may have become more dangerous than the episode itself. “Doctors were baffled by it,” said Benjamin Radford, the investigator who co-authored a paper on the phenomenon. “That w...
In a pair of studies, scientists at the National Institutes of Health explored how the human brain stores and retrieves memories. One study suggests that the brain etches each memory into unique firing patterns of individual neurons. Meanwhile, the second study The studies were led by Kareem Zaghloul, M.D., Ph.D., a neurosurgeon-researcher at the NIH’s National Institute of Neurological Disorders and Stroke (NINDS). Persons with drug resistant epilepsy in protocols studying surgical resection of their seizure focus at the NIH’s Clinical Center enrolled in this study. To help locate the source of the seizures, Dr. Zaghloul’s team surgically implanted a grid of electrodes into the patients’ brains and monitored electrical activity for several days.
A study conducted in the US has hit upon a new strategy to identify genes that underlie specific brain processes, and may eventually help scientists develop treatments for patients with memory impairments. More than 100 genes linked to memory have been identified, paving the way for treatments for conditions like epilepsy and Alzheimer’s disease.
Most people are aware that flashing and strobe lights can trigger a seizure in some individuals with epilepsy, but few realize that certain still images can have the same effect. Doctors have remained puzzled as to why certain motionless photos can trigger seizures, but now new research has unveiled the reason. A study published in Current Biology found certain patterns can trigger a specific part of the brain, causing gamma-oscillation, which in some cases, can induce a seizure.
Kathryn Campbell and her pup Soldier are together 24/7 — at home, at school, beside each other in bed every night. So it makes perfect sense that the 5-year-old pooch would share a page with his best friend in The Creek Yearbook — serving as a sweet reminder of everything the two have done together during their freshman year (the school’s newspaper offered the world a peek at the page on Facebook on May 16, the day the book became available)
For the first time, scientists have demonstrated that a component of cannabis reduces seizures in children with a rare form of epilepsy, marking a significant step in efforts to use marijuana and its derivatives to treat serious medical conditions.
A Georgia high school athlete has found himself in the middle of a medicinal cannabis debate, as school officials refuse to let the student, who suffers from epilepsy, take his medicinal cannabis oil on campus at lunch.
GlaxoSmithkline (GSK) announced that its epilepsy seizure drug Trobalt (retigabine) will no longer be commercially available after June 2017. The company has advised healthcare providers to seek alternative medicines for patients as soon as possible and ensure that all patients are withdrawn from Trobalt by the end of June.
EpiFinder, Inc., is pleased to announce its proprietary clinical decision analytics software to improve epilepsy syndrome diagnosis and seizure event management at the point-of-care. The early-stage Arizona company provides intelligent analytics and support to doctors, neurologists and healthcare professionals (Nurse Practitioners, Physician Assistants, and more) to enhance the lives of patients with epilepsy.
The US health regulator has denied approval to Sun Pharma Advanced Research Company’s (SPARC) new drug application for Elepsia XR, an anti-epileptic drug. The company has received a Complete Response Letter (CRL) from the USFDA for its new drug application for Elepsia XR, Levetiracetam extended-release tablets in strengths of 1,000 mg and 1,500 mg, SPARC said in a regulatory filing.
A University of Warwick study to understand a form of epilepsy that affects children has received a grant from the charity Epilepsy Research UK. The research focuses on absence epilepsy which is largely a childhood condition which is characterized by sudden, brief interruptions of consciousness. In severe cases there may be more than 200 of these episodes each day, and these can be accompanied by or develop into convulsive seizures. Many children with absence seizures don’t respond to existing antiepileptic medication, which can present numerous difficulties in daily life, particularly with schooling.
Elizabeth Szasz is 12 years old but is unable to lead the typical life of a middle schooler. She was diagnosed with epilepsy as a baby and has tried several treatments for her life-threatening seizures. Each new treatment would work for a short time. But her seizures, which can last longer than two hours would return. Her parents say they felt hopeless.